Clinical Trial Update: A Second-generation AI Based Therapeutic Regimen in Patients With Gaucher Disease Treated With Enzyme Replacement Therapy. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial reports on a second-generation AI-based therapeutic regimen for Gaucher disease type 1 in patients already treated with enzyme replacem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• Enzyme Replacement Therapy (enzyme replacement therapy)
• Second-generation AI-based therapeutic regimen

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Gaucher Disease Type 1 | Phase 2 | Status: COMPLETED